BioCentury
ARTICLE | Company News

Echelon Research Laboratories Inc. other research news

March 19, 2001 8:00 AM UTC

Echelon received a $940,000 Phase II SBIR grant from the National Institute of General Medical Sciences to develop its Shuttle-PIP technology to deliver signal transduction-regulating molecules to tre...